Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | GALR3 | O60755 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | NPY1R | P25929 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | RAD52 | P43351 | 1/20 | 0.31 |
| ▸ | NPY2R | P49146 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | HEXA | P06865 | 1/20 | 0.31 |
| ▸ | HEXB | P07686 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25497596 | 0.88 | MEN1 (0.31) | MEN1NPC1GALR3ALDH1A1POLB | |
| SCHEMBL26013138 | 0.85 | NPC1 (0.31) | NPC1RAB9ASMN1; SMN2HEXAHEXB | |
| SCHEMBL25517571 | 0.83 | LMNA (0.32) | MEN1NPC1ALDH1A1MAPTHTT | |
| SCHEMBL26014288 | 0.82 | NPC1 (0.31) | NPC1RAB9ASMN1; SMN2HEXAHEXB | |
| SCHEMBL25968253 | 0.77 | HDAC8 (0.32) | MEN1NPC1GALR3ALDH1A1POLB | |
| SCHEMBL25445552 | 0.77 | RAB9A (0.35) | MEN1NPC1GALR3ALDH1A1POLB | |
| SCHEMBL25967922 | 0.77 | CNR2 (0.33) | MEN1NPC1GALR3ALDH1A1POLB | |
| SCHEMBL25638907 | 0.76 | CA12 (0.33) | MEN1NPC1GALR3ALDH1A1POLB | |
| SCHEMBL25445897 | 0.76 | ALDH1A1 (0.32) | MEN1NPC1ALDH1A1MAPTHTT | |
| SCHEMBL25968275 | 0.76 | HEXA (0.31) | HEXAHEXB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230209990-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230209990-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | L3MBTL3, AGO2, ELAVL3 | MEN1 766/4885NPC1 1321/4885GALR3 153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.